|
0
|
|
Daraxonrasib for Previously Treated RAS-Mutant Non-Small-Cell Lung Cancer.
(nejm.org)
|
Arbour KC
…
Hong DS
New England Journal of Medicine
2026-09-03
|
#clinical trial
#nsclc
#ras
#inhibitor
#oncology
|
|
0
|
|
Azacitidine-Venetoclax or Induction Chemotherapy for Acute Myeloid Leukemia.
(nejm.org)
|
Fathi AT
…
Aldoss I
New England Journal of Medicine
2026-09-03
|
#leukemia
#clinical trial
#chemotherapy
#hypomethylating-agents
|
|
0
|
|
Enhancing Gemcitabine Uptake by Promoting Dimerization of the ENT1 Transporter Improves Sarcoma Patient Response Rate.
(jci.org)
|
Ganju A
…
Kolesnick R
Journal of Clinical Investigation
2026-09-03
|
#chemotherapy
#sarcoma
#clinical trial
#drug-transport
#gemcitabine
|
|
0
|
|
First-line tislelizumab plus chemotherapy versus placebo plus chemotherapy in unresectable advanced/metastatic esophageal squamous cell carcinoma: minimum 3-year survival follow-up of a randomized phase 3 trial (RATIONALE-306).
(nature.com)
|
Yoon HH
…
Xu J
Nature Communications
2026-09-03
|
#cancer
#clinical trial
#immunotherapy
#chemotherapy
#esophageal
|